Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 71 of the 71 references it cites were found in a registry or an index.

Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis

Open access

Abstract

The gut commensal Bacteroides fragilis or its capsular polysaccharide A (PSA) can prevent various peripheral and CNS sterile inflammatory disorders. Fatal herpes simplex encephalitis (HSE) results from immune pathology caused by uncontrolled invasion of the brainstem by inflammatory monocytes and neutrophils. Here we assess the immunomodulatory potential of PSA in HSE by infecting PSA or PBS treated 129S6 mice with HSV1, followed by delayed Acyclovir (ACV) treatment as often occurs in the clinical setting. Only PSA-treated mice survived, with dramatically reduced brainstem inflammation and altered cytokine and chemokine profiles. Importantly, PSA binding by B cells is essential for induction of regulatory CD4 + and CD8 + T cells secreting IL-10 to control innate inflammatory responses, consistent with the lack of PSA mediated protection in Rag −/− , B cell- and IL-10-deficient mice. Our data reveal the translational potential of PSA as an immunomodulatory symbiosis factor to orchestrate robust protective anti-inflammatory responses during viral infections.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-019-09884-6

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 B. fragilis PSA protects against HSE. a Experimental regimen: In all experiments, PSA (six doses, 50 μg/mouse) or PBS was given orally before HSV infection on day 0 and thereafter daily ip injections of ACV from day 4 pi for 7 days. Survival of wildtype (WT) or Rag mice pre-treated with b B. fragilis, PSA or c PBS, (n = 8–17 mice/group). ****p < 0.001, WT + B. fragilis/PSA vs. Rag + PSA; ns: not significant, WT + PBS vs. Rag + PBS as determined by log rank (Mantel–Cox) test
Fig. 1 B. fragilis PSA protects against HSE. a Experimental regimen: In all experiments, PSA (six doses, 50 μg/mouse) or PBS was given orally before HSV infection on day 0 and thereafter daily ip injections of ACV from day 4 pi for 7 days. Survival of wildtype (WT) or Rag mice pre-treated with b B. fragilis, PSA or c PBS, (n = 8–17 mice/group). ****p < 0.001, WT + B. fragilis/PSA vs. Rag + PSA; ns: not significant, WT + PBS vs. Rag + PBS as determined by log rank (Mantel–Cox) testCC BY · PubMed Central
Fig. 2 PSA reduces CNS inflammation in HSV-infected WT but not Rag mice. a % and b total numbers (#) of CD45high leukocytes and CD45high Ly6Chigh inflammatory monocytes (IM) infiltrating the brainstem (BS) of Rag mice. c % (left y-axis) and # (right y-axis) infiltrating CD45high leukocytes in the BS of WT mice. d % CD11b+ cells within BS infiltrating CD45high cells; e % Ly6Chigh and CD107+ IM within the CD11b+ population; f % CD4+ and CD8+ T cells within CD45high cells in the BS of WT mice. Data compiled from 2 to 4 experiments with n = 6–8/group at day 6 pi. All data show mean ± SEM. ***p < 0.0005, ****p < 0.0001, ns: not significant, as determined by two-tailed Student's t-test
Fig. 2 PSA reduces CNS inflammation in HSV-infected WT but not Rag mice. a % and b total numbers (#) of CD45high leukocytes and CD45high Ly6Chigh inflammatory monocytes (IM) infiltrating the brainstem (BS) of Rag mice. c % (left y-axis) and # (right y-axis) infiltrating CD45high leukocytes in the BS of WT mice. d % CD11b+ cells within BS infiltrating CD45high cells; e % Ly6Chigh and CD107+ IM within the CD11b+ population; f % CD4+ and CD8+ T cells within CD45high cells in the BS of WT mice. Data compiled from 2 to 4 experiments with n = 6–8/group at day 6 pi. All data show mean ± SEM. ***p < 0.0005, ****p < 0.0001, ns: not significant, as determined by two-tailed Student's t-testCC BY · PubMed Central
Fig. 3 PSA protection from HSE is independent of induced Tregs. a % FoxP3+ CD4 Tregs and b CD69+ CD4 T cells in spleen and CLN of PSA or PBS-treated WT mice at day 6 pi. c CD25 expression within FoxP3+ CD4 Tregs in WT mice at day 6 pi, % and mean fluorescence intensity (MFI) in () shown in right top quadrant. d % CD25 within FoxP3+ Tregs (left plot) and FoxP3− CD4+ T cells (right plot), e CD103 expression within FoxP3+ Tregs in WT mice at day 6 pi; % and MFI in () shown in right top quadrant. f CD103 within FoxP3+ Tregs (left plot) and FoxP3− CD4+ T cells (right plot) in the spleen or CLN of WT mice at day 6 pi. Data from three experiments shown. g PSA-treated Treg depleted and control WT mice were monitored for survival after HSV infection and ACV treatment as in Fig. 1a, ns: not significant determined by log rank Mantel–Cox test (n = 11–12 mice). After administration of three (1 week) or six doses (2 weeks) of PSA, MLN in uninfected WT mice were monitored for h cellularity, i % CD4 and CD8 T cells, and j # ICOS+, CD39+, and CD73+ CD4 and CD8 T cells (n = 3 mice); ****p < 0.0001, **p < 0.01 as determined by two-way ANOVA or one-way ANOVA with Sidaks or Turkeys correction, respectively, for multiple comparisons tests. All data show mean ± SEM
Fig. 3 PSA protection from HSE is independent of induced Tregs. a % FoxP3+ CD4 Tregs and b CD69+ CD4 T cells in spleen and CLN of PSA or PBS-treated WT mice at day 6 pi. c CD25 expression within FoxP3+ CD4 Tregs in WT mice at day 6 pi, % and mean fluorescence intensity (MFI) in () shown in right top quadrant. d % CD25 within FoxP3+ Tregs (left plot) and FoxP3− CD4+ T cells (right plot), e CD103 expression within FoxP3+ Tregs in WT mice at day 6 pi; % and MFI in () shown in right top quadrant. f CD103 within FoxP3+ Tregs (left plot) and FoxP3− CD4+ T cells (right plot) in the spleen or CLN of WT mice at day 6 pi. Data from three experiments shown. g PSA-treated Treg depleted and control WT mice were monitored for survival after HSV infection and ACV treatment as in Fig. 1a, ns: not significant determined by log rank Mantel–Cox test (n = 11–12 mice). After administration of three (1 week) or six doses (2 weeks) of PSA, MLN in uninfected WT mice were monitored for h cellularity, i % CD4 and CD8 T cells, and j # ICOS+, CD39+, and CD73+ CD4 and CD8 T cells (n = 3 mice); ****p < 0.0001, **p < 0.01 as determined by two-way ANOVA or one-way ANOVA with Sidaks or Turkeys correction, respectively, for multiple comparisons tests. All data show mean ± SEMCC BY · PubMed Central
Fig. 4 PSA increases IL-10 and IFNγ-secreting T cells. CD4 and CD8 T cells and B cells in spleens, mesenteric lymph nodes (MLN), and cervical lymph nodes (CLN) of PSA or PBS-treated WT mice at day 6 pi were analyzed for a IL-10 and b IFNγ secretion, n = 2 experiments; *p < 0.05, **p < 0.01, ****p < 0.0001, as determined by two-way ANOVA with Sidak’s multiple comparisons test. Survival of PSA or PBS treated c IL-10KO mice or d IFN-GKO mice (n = 8–16 mice); ns: not significant. Bar plots show e % CD45high leukocytes, f (left y-axis) % Ly6Chigh IM and (right y-axis) % Ly6G+ neutrophils (PMN) within CD45high CD11b+ cells infiltrating the BS of PSA treated 129 WT, IL10KO, and GKO mice at day 6 pi, n = 3 experiments with 2–3 BS/group; *p < 0.05, ****p < 0.0001 as determined by ordinary one-way ANOVA with Turkey’s multiple comparisons tests
Fig. 4 PSA increases IL-10 and IFNγ-secreting T cells. CD4 and CD8 T cells and B cells in spleens, mesenteric lymph nodes (MLN), and cervical lymph nodes (CLN) of PSA or PBS-treated WT mice at day 6 pi were analyzed for a IL-10 and b IFNγ secretion, n = 2 experiments; *p < 0.05, **p < 0.01, ****p < 0.0001, as determined by two-way ANOVA with Sidak’s multiple comparisons test. Survival of PSA or PBS treated c IL-10KO mice or d IFN-GKO mice (n = 8–16 mice); ns: not significant. Bar plots show e % CD45high leukocytes, f (left y-axis) % Ly6Chigh IM and (right y-axis) % Ly6G+ neutrophils (PMN) within CD45high CD11b+ cells infiltrating the BS of PSA treated 129 WT, IL10KO, and GKO mice at day 6 pi, n = 3 experiments with 2–3 BS/group; *p < 0.05, ****p < 0.0001 as determined by ordinary one-way ANOVA with Turkey’s multiple comparisons testsCC BY · PubMed Central
Fig. 5 PSA protection against HSE requires B and T cells secreting IL-10. a Experimental design for experiments in b and c Donor WT (In black text): Naïve Rag mice were transferred with WT CD4+ or CD8+ T cells or CD19+ B cells 7 days before PSA treatment. Donor IL-10KO (magenta text) and WT (Blue text): four groups of naïve Rag mice were transferred with combinations of donor WT B and T cells, IL-10KO B and T cells, WT B and IL-10KO T cells, IL-10KO B and WT T cells 7-days before PSA treatment. All Rag recipients received six doses of PSA before HSV infection and ACV treatment. b Survival of B cell-depleted mice (BKO, n = 20 mice) and Rag recipients of WT single cell subsets (n = 6–9 mice/group). B cell depletion in WT mice was initiated 10 days prior to PSA treatment and continued throughout infection, ns: not significant. c Survival of Rag recipients of WT and IL-10KO combination of T and B cells (n = 10–13/group). ***p < 0.001, *p < 0.05, ns: not significant as determined by log rank (Mantel–Cox) test. FACS plots of BS CD45high cells (left), Ly6G+ PMN (left middle), CD11b+ cells within CD45high cells (right middle), and Ly6Chigh IM and Ly6Cint CD11b+ PMN within CD45high CD11b+ cells (right) were analyzed at day 6 pi in the BS of Rag recipients of d IL-10KO B + WT T cells (brown circle) and e WT B + IL-10KO T cells (green circle)
Fig. 5 PSA protection against HSE requires B and T cells secreting IL-10. a Experimental design for experiments in b and c Donor WT (In black text): Naïve Rag mice were transferred with WT CD4+ or CD8+ T cells or CD19+ B cells 7 days before PSA treatment. Donor IL-10KO (magenta text) and WT (Blue text): four groups of naïve Rag mice were transferred with combinations of donor WT B and T cells, IL-10KO B and T cells, WT B and IL-10KO T cells, IL-10KO B and WT T cells 7-days before PSA treatment. All Rag recipients received six doses of PSA before HSV infection and ACV treatment. b Survival of B cell-depleted mice (BKO, n = 20 mice) and Rag recipients of WT single cell subsets (n = 6–9 mice/group). B cell depletion in WT mice was initiated 10 days prior to PSA treatment and continued throughout infection, ns: not significant. c Survival of Rag recipients of WT and IL-10KO combination of T and B cells (n = 10–13/group). ***p < 0.001, *p < 0.05, ns: not significant as determined by log rank (Mantel–Cox) test. FACS plots of BS CD45high cells (left), Ly6G+ PMN (left middle), CD11b+ cells within CD45high cells (right middle), and Ly6Chigh IM and Ly6Cint CD11b+ PMN within CD45high CD11b+ cells (right) were analyzed at day 6 pi in the BS of Rag recipients of d IL-10KO B + WT T cells (brown circle) and e WT B + IL-10KO T cells (green circle)CC BY · PubMed Central
Fig. 6 TLR2+ macrophages, pDCs, and PB in the small intestine bind PSA and induce IL-10 secretion. Gating strategy for mononuclear cells isolated from a duodenum (Duod) and b ileum (Ile) of WT and Rag mice analyzed for binding of fluorescent A488-conjugated PSA (left two plots). CD45− intra-epithelial cells (CD45− IEC: middle histogram) and CD45+ gated intra-epithelial leukocytes (CD45+ IEL: second right histogram) isolated from the a Duod and b Ile of WT (red) and Rag (blue) mice were analyzed for reactivity to PSA-A488. CD45+CD11c−B220+ B cells, PDCA1+ B220+CD11c+ pDCs and CD138+B220+ PB and B220low PC isolated from a Duod and b Ile of WT mice were analyzed for PSA reactivity (right histogram). Flow cytometry plots show CD11c+PDCA1− cDC, PDCA1+B220+ pDC, and B220+CD19+ B cells isolated from spleen, MLN, PP, IEL, or LP of WT mice were stimulated with c PSA or d LTA-SA (TLR2 agonist) and analyzed for IL-10 expression. e Plots summarize data from c and d and show % IL-10+ B cells (left), cDCs (middle), and pDCs (right) from spleen, MLN, PP, IEL, and LP stimulated with PSA or TLR2 (LTA-SA) (n = 3 mice). All data show mean ± SEM
Fig. 6 TLR2+ macrophages, pDCs, and PB in the small intestine bind PSA and induce IL-10 secretion. Gating strategy for mononuclear cells isolated from a duodenum (Duod) and b ileum (Ile) of WT and Rag mice analyzed for binding of fluorescent A488-conjugated PSA (left two plots). CD45− intra-epithelial cells (CD45− IEC: middle histogram) and CD45+ gated intra-epithelial leukocytes (CD45+ IEL: second right histogram) isolated from the a Duod and b Ile of WT (red) and Rag (blue) mice were analyzed for reactivity to PSA-A488. CD45+CD11c−B220+ B cells, PDCA1+ B220+CD11c+ pDCs and CD138+B220+ PB and B220low PC isolated from a Duod and b Ile of WT mice were analyzed for PSA reactivity (right histogram). Flow cytometry plots show CD11c+PDCA1− cDC, PDCA1+B220+ pDC, and B220+CD19+ B cells isolated from spleen, MLN, PP, IEL, or LP of WT mice were stimulated with c PSA or d LTA-SA (TLR2 agonist) and analyzed for IL-10 expression. e Plots summarize data from c and d and show % IL-10+ B cells (left), cDCs (middle), and pDCs (right) from spleen, MLN, PP, IEL, and LP stimulated with PSA or TLR2 (LTA-SA) (n = 3 mice). All data show mean ± SEMCC BY · PubMed Central
Fig. 7 Role of the bacterial symbiosis factor PSA in preventing viral encephalitis. HSV infection of susceptible 129 WT mice provokes excessive production of neutrophils (PMN) and Ly6Chigh inflammatory monocytes (IM) in the bone marrow that invade the brainstem in massive numbers resulting in fatal HSV encephalitis (HSE), despite antiviral treatment from day 4 pi. The bacterial symbiosis factor, PSA given orally is bound by B cells/CD138+ plasmablasts (PB) in the small intestine, which induces IL-10 and IFNγ production by regulatory CD4 and CD8 T cells resulting in the suppression of pathogenic inflammatory myeloid cells concomitant with the induction of IFNγ inducible chemokines in the BS. This novel study reveals the immunomodulatory potential of PSA in protecting from lethal viral infections of the CNS in combination with an antiviral. Cells involved in this protective mechanism are shown in the key. Inhibitory pathways indicated by red blocking arrows
Fig. 7 Role of the bacterial symbiosis factor PSA in preventing viral encephalitis. HSV infection of susceptible 129 WT mice provokes excessive production of neutrophils (PMN) and Ly6Chigh inflammatory monocytes (IM) in the bone marrow that invade the brainstem in massive numbers resulting in fatal HSV encephalitis (HSE), despite antiviral treatment from day 4 pi. The bacterial symbiosis factor, PSA given orally is bound by B cells/CD138+ plasmablasts (PB) in the small intestine, which induces IL-10 and IFNγ production by regulatory CD4 and CD8 T cells resulting in the suppression of pathogenic inflammatory myeloid cells concomitant with the induction of IFNγ inducible chemokines in the BS. This novel study reveals the immunomodulatory potential of PSA in protecting from lethal viral infections of the CNS in combination with an antiviral. Cells involved in this protective mechanism are shown in the key. Inhibitory pathways indicated by red blocking arrowsCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 71 references

Cited by

See all 284

Metadata

Authors
Ramakrishna, C., Kujawski, M., Chu, H., Li, L., Mazmanian, S. K., & Cantin, E. M.
Affiliations
  • City Of Hope National Medical Center (US)
  • California Institute of Technology (US)
Corresponding author
  • Ramakrishna, Chandran
  • Cantin, Edouard M.
Venue
Nature Communications
Published
2019-05-14
Volume
10
Issue
1
Pages
2153-2153
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2945318499
Cited by
284
References
71
Citations by year
2026: 24 · 2025: 44 · 2024: 42 · 2023: 47 · 2022: 42 · 2021: 45 · 2020: 29 · 2019: 8
FWCI
12.39
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • CaltechAUTHORS (California Institute of Technology) (submittedVersion, cc-by)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
Funders
  • California Institute of Technology
  • Servier
  • Genentech
  • Medical Research Council
  • National Institute of Diabetes and Digestive and Kidney Diseases (R00DK110534, K99DK110534)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
  • Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
Keywords
Bacteroides fragilis, polysaccharide A, herpes simplex encephalitis, herpes simplex virus type 1, IL-10, regulatory T cells, regulatory B cells, gut commensals, immunomodulation, brainstem inflammation, anti-inflammatory response, symbiosis, Rag1-deficient mice, IL-10-deficient mice
MeSH terms
Gastrointestinal Microbiome, Host Microbial Interactions, Acyclovir, Animals, Antiviral Agents, B-Lymphocytes, Bacteroides fragilis, Chlorocebus aethiops, Disease Models, Animal, Female, Humans, Male, Polysaccharides, Bacterial, Symbiosis, T-Lymphocytes, Vero Cells, Interleukin-10, Herpesvirus 1, Human, Mice, Knockout, Encephalitis, Herpes Simplex, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis. https://app.cochat.ai/papers/10.1038/s41467-019-09884-6
The paper
Ramakrishna, C., Kujawski, M., Chu, H., Li, L., Mazmanian, S. K., & Cantin, E. M. (2019). Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis. Nature Communications. https://doi.org/10.1038/s41467-019-09884-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.